In particular, High Tech's big companies, which reported well above expectations, led the Nasdaq toward a new maximum.
The strategy adopted for our portfolio, we can summarize it in:
- maintaining high weight for Biotech and Pharma titles;
- overweight technology and banking securities.
We attach schedule of the portfolio.